Resistance patterns in clinical isolates of pathogenic Actinomyces species

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 2, 2016, Pages 422-427

  Steininger, C ^a   Willinger, Birgit ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFOTAXIME; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; FUSIDIC ACID; IMIPENEM; LINEZOLID; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; PENICILLIN G; SULTAMICILLIN; TETRACYCLINE DERIVATIVE; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACTINOMYCES; ACTINOMYCES EUROPAEUS; ACTINOMYCES ISRAELII; ACTINOMYCES MEYERI; ACTINOMYCES NAESLUNDII; ACTINOMYCES NEUII; ACTINOMYCES ODONTOLYTICUS; ACTINOMYCES ORIS; ACTINOMYCES RADINGAE; ACTINOMYCES TURICENSIS; ACTINOMYCOSIS; ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; COMMENSAL; EPSILOMETER TEST; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RETROSPECTIVE STUDY; AEROBIC METABOLISM; ANAEROBIC GROWTH; DISK DIFFUSION; DRUG EFFECTS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; TERTIARY CARE CENTER;

ACTINOMYCES; ACTINOMYCOSIS; AEROBIOSIS; ANAEROBIOSIS; ANTI-BACTERIAL AGENTS; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG RESISTANCE, BACTERIAL; HUMANS; RETROSPECTIVE STUDIES; TERTIARY CARE CENTERS;

EID: 84959932775     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv347     Document Type: Article

References (18)

1. Kononen E, Wade WG. Actinomyces and related organisms in human infections. Clin Microbiol Rev 2015; 28: 419-42.
2. Smego RA Jr, Foglia G. Actinomycosis. Clin Infect Dis 1998; 26: 1255-61.
3. Wong VK, Turmezei TD, Weston VC. Actinomycosis. BMJ 2011; 343: d6099.
4. Nedomansky J, Weiss D, Willinger B et al. Acne inversa complicated by Actinomyces neuii. Infection 2015; doi:10.1007/s15010-015-0814-6.
5. Hansen T, Kunkel M, Springer E et al. Actinomycosis of the jaws-histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis. Virchows Arch 2007; 451: 1009-17.
6. Pulverer G, Schutt-Gerowitt H, Schaal KP. Human cervicofacial actinomycoses: microbiological data for 1997 cases. Clin Infect Dis 2003; 37: 490-7.
7. De CJ, Tacconelli E, Vandecasteele SJ. Actinomyces osteomyelitis in bisphosphonate-related osteonecrosis of the jaw (BRONJ): the missing link? Eur J Clin Microbiol Infect Dis 2014; 33: 1873-80.
8. Marchand-Austin A, Rawte P, Toye B et al. Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010-2011. Anaerobe 2014; 28: 120-5.
9. Smith AJ, Hall V, Thakker B et al. Antimicrobial susceptibility testing of Actinomyces species with 12 antimicrobial agents. J Antimicrob Chemother 2005; 56: 407-9.
10. Clinical and Laboratory Standards Institute. Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria-Seventh Edition: Approved Standard M11-A7. CLSI, Wayne, PA, USA, 2007.
11. National Committee for Clinical Laboratory Standards. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes: Approved Standard M24-A. NCCLS, Wayne, PA, USA, 2003.
12. Nguyen MH, Yu VL, Morris AJ et al. Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial. Clin Infect Dis 2000; 30: 870-6.
13. Roberts SA, Shore KP, Paviour SD et al. Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003. J Antimicrob Chemother 2006; 57: 992-8.
14. Boyanova L, Kolarov R, Mitov I. Recent evolution of antibiotic resistance in the anaerobes as compared to previous decades. Anaerobe 2015; 31: 4-10.
15. Wang FD, Liao CH, Lin YT. et al. Trends in the susceptibility of commonly encountered clinically significant anaerobes and susceptibilities of blood isolates of anaerobes to 16 antimicrobial agents, including fidaxomicin and rifaximin, 2008-2012, northern Taiwan. Eur J Clin Microbiol Infect Dis 2014; 33: 2041-52.
16. McNeil MM, Schaal KP. Actinomyces species (actinomycoses) In: Yu VL, Weber R, Raoult D, eds. Antimicrobial Therapy and Vaccines. 2nd edn. New York: Apple Tree Productions, 2002; 29-40.
17. Martin MV. Antibiotic treatment of cervicofacial actinomycosis for patients allergic to penicillin: a clinical and in vitro study. Br J Oral Maxillofac Surg 1985; 23: 428-34.
18. Schaal KP, Lee HJ. Actinomycete infections in humans-a review. Gene 1992; 115: 201-11.